Sunridge International's Patented 'PNT' Procedure is Topic of Health News Digest Recent Article
January 26 2010 - 9:00AM
PR Newswire (US)
FOUNTAIN HILLS, Ariz., Jan. 26 /PRNewswire-FirstCall/ -- Sunridge
International's, (OTC:SNDZ) (BULLETIN BOARD: SNDZ) patented "PNT"
procedure was the topic of discussion in one of Health News
Digest's recent articles published on January 24, 2010.
http://www.healthnewsdigest.com/news/contributing%20columnist0/The_Vision_
Thing--For_Real.shtml HealthNewsDigest.com network publishes 24/7,
covering breaking news, articles, stories, and features on health,
science and the environment. HND's content currently appears in 164
countries, being distributed through their website as well as
Google Worldwide, Topix World News, Congoo World News, and an over
4,000 additional websites. G. Richard Smith, CEO of Sunridge
International, stated, "Articles like this go a long way to help
inform the public of how severe glaucoma is and what preventative
actions should be taken. As mentioned in the article, 'PNT can also
be used for newly diagnosed patients who have yet to undergo
pharmaceutical approaches,' and it is our goal at Sunridge
International to expand our marketing efforts so that one day the
newly diagnosed population, along with the current glaucoma
sufferers from around the globe can receive the 'PNT' procedure to
help stop the progression of this disease." Glaucoma is the second
leading cause of blindness, effecting over 70 million people
worldwide. PNT has been proven (through studies completed over the
last 10 yrs) to be a safe and effective treatment with no adverse
side effects associated with it, unlike typical forms of glaucoma
treatment. Forward-looking statements in this release are made
pursuant to the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. Investors are cautioned that such
forward-looking statements involve risks and uncertainties,
including without limitation, continued acceptance of the company's
products, increased levels of competition for the company, new
products and technological changes, the company's dependence on
third-party suppliers, and other risks detailed from time to time
in the company's periodic reports filed with the Securities and
Exchange Commission. DATASOURCE: Sunridge International CONTACT:
Jeff Smith, +1-602-363-6344, , for Sunridge International
Copyright